UN "flaws" attacked on World Health Day
A former head of the Office of Biotechnology at the USA's Food and Drug Administration has upstaged the World Health Organization's World Health Day, by denouncing the agency as part of the problem. Henry Miller, a physi-cian and now a fellow at the Stanford, California, USA-based think-tank the Hoover Institution, criticized the United Nations' "anti-corporate bias," especially what he described as the "unscientific, ideological and excessive regulation of biotechnology."
The Geneva-headquartered WHO used World Health Day to issue a report on the global health care workforce. The World Health Report 2006 - Working together for health was issued on April 7, drawing attention to the problem of skilled personnel shortages in developing countries.
Biotech regulation "a travesty"
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
Free
7 day trial access
- All the news that moves the needle in pharma and biotech
- Exclusive features, podcasts, interviews, data analyses and commentary from our global network of life sciences reporters.
- Receive The Pharma Letter daily news bulletin, free forever.
Become a subscriber
£820
Or £77 per month
- Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
- Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
- Daily roundup of key events in pharma and biotech.
- Monthly in-depth briefings on Boardroom appointments and M&A news.
- Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Today's issue
Company Spotlight
Copyright © The Pharma Letter 2024 | Headless Content Management with Blaze